Viking Therapeutics logo
Viking Therapeutics VKTX
$ 52.15 1.2%

Quarterly report 2024-Q3
added 10-23-2024

report update icon

Viking Therapeutics Long Term Debt Current 2011-2024 | VKTX

Annual Long Term Debt Current Viking Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
324 K 304 K 29 K 330 K 302 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
330 K 29 K 258 K